Published Date: 02 Mar 2023
A deep learning model called Sybil can predict future lung cancer risk based on a low-dose chest CT scan and identify people who are likely to benefit from regular treatment.
Read Full NewsA recent trial assesses whether the addition of quizartinib following intensive chemotherapy improves survival outcomes in older patients with previously untreated AML.
The newly approved inhibitor is for patients who previously received another drug of the same class.
1.
The discovery of drug combinations may increase the life expectancy of children with brain cancer.
2.
To refute accusations that it failed to issue a cancer warning, Roundup's maker is asking lawmakers for assistance.
3.
High levels of traumatic stress found in caregivers of adult cancer patients
4.
These Athletes Weren't Doping. Their Genes Made It Look Like They Did.
5.
Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases
1.
Uncovering the Mysteries of Breast Cancer: The Journey to a Cure
2.
Mast Cell-Tumor Cell Interactions in OSCC: Genetic and microRNA Insights
3.
Progressive Updates in Oncology for Healthcare Excellence
4.
Revolutionizing Lung Transplantation: The Promise of Donor-Specific Blood Transfusion
5.
Understanding Waldenstrom Macroglobulinemia - A Comprehensive Guide
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
2.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
3.
Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment
4.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
5.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation